stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Savara IncSVRA
$4.473.77%-0.175

Savara Inc (SVRA)

Savara Inc stock is traded at $4.47, with a volume of 2,768,755. It is down -3.77% in the last 24 hours and up +0.34% over the past month. Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Previous Close:
$4.64
Open:
$4.70
24h Volume:
2,768,755
Relative Volume:
0.80
Market Cap:
$985.08M
Revenue:
-
Net Income/Loss:
-$129.48M
P/E Ratio:
-
EPS:
-$0.5584
Net Cash Flow:
-$106.97M
1W Performance:
-11.58%
1M Performance:
+0.34%
6M Performance:
-11.23%
1Y Performance:
+3.84%
1-Day Range:
$4.40$4.74
1-Week Range:
$4.40$5.21
52-Week Range:
$4.13$7.01

Savara Inc Stock (SVRA) Company Profile

Name
Savara Inc
Phone
51285113796
Address
6836 BEE CAVE ROAD, AUSTIN, TX, USA
Employee
70
Next Earnings Date
-
Latest SEC Filings
SEC
SVRA's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Savara Inc Stock (SVRA) Financials Data

Similar to SVRA